|
| Sánchez-Ibarra, Héctor E. et al. Complete Screening of Exons 2, 3, and 4 of KRAS and NRAS Genes Reveals a Higher Number of Clinically Relevant Mutations than Food and Drug Administration Quantitative Polymerase Chain Reaction-Based Commercial Kits. Rev. invest. clín., Dec 2020, vol.72, no.6, p.337-343. ISSN 0034-8376
|
|